文献速递神经核医学

早期[18F]PI-2620 tau-PET显像作为神经元损伤的替代标志物

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-04-21

研究纳入26例疑似tau蛋白病或重叠帕金森综合征患者,比较动态[18F]PI-2620 tau-PET早期显像与静态[18F]FDG-PET的相关性。结果显示0.5-2.5分钟早期[18F]PI-2620 SUVr和R1与[18F]FDG-PET定量高度一致,视觉判读经验不同读者间无相关差异。结论认为[18F]PI-2620早期显像可作为神经元损伤的替代生物标志物。

要点

  • 26例疑似tau蛋白病或重叠帕金森综合征患者接受动态[18F]PI-2620 tau-PET和静态[18F]FDG-PET。
  • 0.5-2.5分钟早期[18F]PI-2620 SUVr与R1和[18F]FDG-PET定量相关性最高。
  • 视觉判读显示早期tau-PET与[18F]FDG-PET区域相关性高,经验不同读者间无相关差异。

核心结论

  • [18F]PI-2620早期显像可作为神经元损伤的替代生物标志物。
  • 动态显像或双时间点tau-PET方案可同时反映tau分布和神经元损伤程度,可能取代额外的[18F]FDG-PET显像。

研究设计与样本

  • 研究纳入26例疑似tau蛋白病或重叠帕金森综合征患者,包括阿尔茨海默病、进行性核上性麻痹、皮质基底节综合征、多系统萎缩、帕金森病和额颞叶痴呆。
  • 患者接受动态[18F]PI-2620 tau-PET(注射后0-60分钟)和静态[18F]FDG-PET(注射后30-50分钟)。
  • 计算早期显像单帧SUVr和血流估计值R1与[18F]FDG-PET定量的Spearman秩相关系数。
  • 由三名较有经验和三名较无经验的读者采用三维立体定向表面投影视觉判读皮质靶区示踪剂摄取减低。

主要发现

  • [18F]PI-2620-PET注射后0.5-2.5分钟采集与[18F]FDG-PET定量一致性最高,全局均值归一化最低R=0.69,小脑归一化最低R=0.63。
  • 0.5-2.5分钟SUVr与R1汇总的相关系数在全部皮质靶区显示强一致性:全局均值归一化RSUVr 0.76、RR1=0.77;小脑归一化RSUVr 0.68、RR1=0.68。
  • 视觉判读显示早期tau-PET与[18F]FDG-PET区域相关性高,较有经验与较无经验读者间无相关差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Second-generation tau radiotracers for use with positron emission tomography (PET) have been developed for visualization of tau deposits in vivo. For several β-amyloid and first-generation tau-PET radiotracers, it has been shown that early-phase images can be used as a surrogate of neuronal injury. Therefore, we investigated the performance of early acquisitions of the novel tau-PET radiotracer [18F]PI-2620 as a potential substitute for [18F]fluorodeoxyglucose ([18F]FDG). METHODS: Twenty-six subjects were referred with suspected tauopathies or overlapping parkinsonian syndromes (Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, multi-system atrophy, Parkinson's disease, multi-system atrophy, Parkinson's disease, frontotemporal dementia) and received a dynamic [18F]PI-2620 tau-PET (0-60 min p.i.) and static [18F]FDG-PET (30-50 min p.i.). Regional standardized uptake value ratios of early-phase images (single frame SUVr) and the blood flow estimate (R1) of [18F]PI-2620-PET were correlated with corresponding quantification of [18F]FDG-PET (global mean/cerebellar normalization). Reduced tracer uptake in cortical target regions was also interpreted visually using 3-dimensional stereotactic surface projections by three more and three less experienced readers. Spearman rank correlation coefficients were calculated between early-phase [18F]PI-2620 tau-PET and [18F]FDG-PET images for all cortical regions and frequencies of disagreement between images were compared for both more and less experienced readers. RESULTS: Highest agreement with [18F]FDG-PET quantification was reached for [18F]PI-2620-PET acquisition from 0.5 to 2.5 min p.i. for global mean (lowest R = 0.69) and cerebellar scaling (lowest R = 0.63). Correlation coefficients (summed 0.5-2.5 min SUVr & R1) displayed strong agreement in all cortical target regions for global mean (RSUVr 0.76, RR1 = 0.77) and cerebellar normalization (RSUVr 0.68, RR1 = 0.68). Visual interpretation revealed high regional correlations between early-phase tau-PET and [18F]FDG-PET. There were no relevant differences between more and less experienced readers. CONCLUSION: Early-phase imaging of [18F]PI-2620 can serve as a surrogate biomarker for neuronal injury. Dynamic imaging or a dual time-point protocol for tau-PET imaging could supersede additional [18F]FDG-PET imaging by indexing both the distribution of tau and the extent of neuronal injury.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Beyer L, Nitschmann A, Barthel H, et al. Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. Eur J Nucl Med Mol Imaging. 2020. PMID: 32318783. doi:10.1007/s00259-020-04788-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。